期刊文献+

CRISPR/Cas9基因编辑技术安全性研究进展

Research progress on the safety of CRISPR/Cas9 gene editing technology
原文传递
导出
摘要 CRISPR/Cas9(Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated nuclease 9)技术凭借效率高、简便、成本低和易操作的特点成为当今主流的基因编辑系统,并被广泛应用于基础研究和临床应用研究。然而,CRISPR/Cas9基因编辑技术潜在的安全风险引起广泛关注。已有研究表明,CRISPR/Cas9基因编辑技术存在脱靶、染色体缺失、碎裂和DNA损伤修复功能异常等安全风险。本文主要对CRISPR/Cas9系统潜在的安全风险与防范策略进行概述,为CRISPR/Cas9系统能更加安全有效的应用于临床提供参考。 CRISPR/Cas9(Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated nuclease 9) technology has emerged as the predominant gene editing system owing to its high efficiency, simplicity, low cost and easy operation. It has been widely used in basic research and clinical application research.However, the potential safety risks of CRISPR/Cas9 gene editing technology have raised widespread concern. Previous studies have shown that CRISPR/Cas9 gene editing technology has safety risks such as off-target, chromosome deletion, chromothripsis and dysfunction of DNA damage repair. This reviewsummarizes the potential security risks and prevention strategiesof CRISPR/Cas9 system, so as to provide reference for the development of safe and effective CRISPR/Cas9 system for clinical application.
作者 方梦雅 宋英杰 靳力 李浩 孙岩松 刘宗平 FANG Mengya;SONG Yingjie;JIN Li;LI Hao;SUN Yansong;LIU Zongping(Institute of Veterinary Medicine,Yangzhou University,Yangzhou 225009,Jiangsu,China;Institute of Microbiology and Epidemiology,Academy of Military Medicine,Academy of Military Sciences)
出处 《中国病原生物学杂志》 CSCD 北大核心 2024年第8期976-979,共4页 Journal of Pathogen Biology
基金 国家自然科学基金项目(No.31901051)。
关键词 CRISPR/Cas9 基因编辑 安全性 风险 综述 CRISPR/Cas9 geneediting safety risks review
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部